2022 in Review

If 2022 was a meme, I think a lot of people and companies would relate with
this one:



From grappling with return to office, changing employee expectations, a
rollercoaster of “will it or won’t it” recession speculation, not to mention
labor shortages and inflation, 2022 was an adventure.


We’ve watched our team, our clients, and our industry weather these
challenges with resiliency, and we’re so proud to work with these people and
in this space.


2022 also had amazing wins! Effective COVID vaccines became freely
available, strides in developing a cancer vaccine were made, and the
Alzheimer’s drug breakthroughs gave hope to patients and families.


At Channel Methods our core mission has always been to support those who
create patient saving therapies. We do this by matching Life Science service
providers capabilities with sponsor project specific needs, with the purpose
of getting drugs to patients quickly and safely.


It’s easy, in the volatility of day-to-day business to forget the impact of good
people working together on improving patients’ lives, so, we would like to
pause and thank our clients, our industry friends, and our sales teams for
every contribution you’ve made in 2022 towards this industry.


Looking forward to working with you in 2023!

 

All of us at Channel Methods

Channel Methods